Unveiling the active sites on ferrihydrite with apparent catalase-like activity for potentiating radiotherapy. (December 2021)
- Record Type:
- Journal Article
- Title:
- Unveiling the active sites on ferrihydrite with apparent catalase-like activity for potentiating radiotherapy. (December 2021)
- Main Title:
- Unveiling the active sites on ferrihydrite with apparent catalase-like activity for potentiating radiotherapy
- Authors:
- Zhang, Ruofei
Chen, Lei
Liang, Qian
Xi, Juqun
Zhao, Hanqing
Jin, Yiliang
Gao, Xingfa
Yan, Xiyun
Gao, Lizeng
Fan, Kelong - Abstract:
- Highlights: Ferrihydrite was found to exhibit catalase-like activity superior to other iron oxides. The surface iron-associated hydroxyl groups were found to act as the catalytic sites of ferrihydrite. Ferrihydrite catalase nanozyme does not possess peroxidase-like, oxidase-like or superoxide dismutase-like activities. The effect of ferrihydrites as catalase-like nanozymes to sensitize radiotherapy was evaluated in vitro and in vivo . The biosafety and biodegradability of ferrihydrite were analyzed. Graphical Abstract: ga1 Abstract: The use of catalase-like nanozymes in relieving tumor hypoxia has been a promising strategy for adjuvant radiotherapy, yet their catalytic mechanism and toxic potential remain elusive. While most studies on catalase-like mechanisms focus on the substrates and products in the catalytic process, little is reported to analyze the dominating surface structure for catalytic activity of nanozymes. Here, we reported the catalase-like activity of ferrihydrite and revealed its structure-activity relationship. Among the ten main forms of iron oxide nanomaterials, ferrihydrite, especially 2-line ferrihydrite, exhibited the highest catalase-like activity. Importantly, the structure-activity fitting and density functional analysis revealed that the abundant surface iron-associated hydroxyl groups dominantly affect the catalase-like activity of ferrihydrites. In addition, the ferrihydrite exhibited no peroxidase-like and superoxide dismutase-like activities,Highlights: Ferrihydrite was found to exhibit catalase-like activity superior to other iron oxides. The surface iron-associated hydroxyl groups were found to act as the catalytic sites of ferrihydrite. Ferrihydrite catalase nanozyme does not possess peroxidase-like, oxidase-like or superoxide dismutase-like activities. The effect of ferrihydrites as catalase-like nanozymes to sensitize radiotherapy was evaluated in vitro and in vivo . The biosafety and biodegradability of ferrihydrite were analyzed. Graphical Abstract: ga1 Abstract: The use of catalase-like nanozymes in relieving tumor hypoxia has been a promising strategy for adjuvant radiotherapy, yet their catalytic mechanism and toxic potential remain elusive. While most studies on catalase-like mechanisms focus on the substrates and products in the catalytic process, little is reported to analyze the dominating surface structure for catalytic activity of nanozymes. Here, we reported the catalase-like activity of ferrihydrite and revealed its structure-activity relationship. Among the ten main forms of iron oxide nanomaterials, ferrihydrite, especially 2-line ferrihydrite, exhibited the highest catalase-like activity. Importantly, the structure-activity fitting and density functional analysis revealed that the abundant surface iron-associated hydroxyl groups dominantly affect the catalase-like activity of ferrihydrites. In addition, the ferrihydrite exhibited no peroxidase-like and superoxide dismutase-like activities, and constantly catalyzed the decomposition of H2 O2 to release O2 in the pH range of 4.0–8.7. With the help of steady and single catalase-like activity in the physiological environment, ferrihydrite safely and effectively catalyzed the H2 O2 in tumor microenvironment to in-situ produce O2 and significantly enhanced the therapeutic effect of radiotherapy. Moreover, ferrihydrite exhibited excellent biosafety and biodegradability. These findings demonstrate the great potential of ferrihydrite as a biocompatible catalase-like nanozyme for relieving hypoxia in cancer therapy. … (more)
- Is Part Of:
- Nano today. Volume 41(2021)
- Journal:
- Nano today
- Issue:
- Volume 41(2021)
- Issue Display:
- Volume 41, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 41
- Issue:
- 2021
- Issue Sort Value:
- 2021-0041-2021-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-12
- Subjects:
- Catalase -- Ferrihydrite -- Structure-activity relationship -- Hypoxia -- Nanozyme -- Radiotherapy
Nanotechnology -- Periodicals
Nanosciences -- Périodiques
620.505 - Journal URLs:
- http://www.sciencedirect.com/science/journal/17480132 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.nantod.2021.101317 ↗
- Languages:
- English
- ISSNs:
- 1748-0132
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6015.335517
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20093.xml